2020 Clinical, Laboratory, Molecular and Pathological (CLMP) criteria for diagnosis and new treatment options of JAK2V617F, JAK2 exon 12, CALR and MPL515 mutated Myeloproliferative Neoplasms: From Dameshek to Vainchenker, Kralovics, Tefferi and Michiels 1940-2020
granulocytic (EMG) proliferation. Two main variants of megakaryocytic leukemia (Dameshek 1951) or ET with platelet counts around 1000x109/L and no features of PV include MPL515 and CALR mutated thrombocythemia…

